510 related articles for article (PubMed ID: 10794480)
1. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
2. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
3. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
Jones NJ; McGregor AD; Waters R
Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
5. Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes.
Besaratinia A; Maas LM; Brouwer EM; Kleinjans JC; Van Schooten FJ
Carcinogenesis; 2000 Jul; 21(7):1335-40. PubMed ID: 10874011
[TBL] [Abstract][Full Text] [Related]
6. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
8. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
9. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
[TBL] [Abstract][Full Text] [Related]
10. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct profiles and levels in placenta, blood and lung in relation to cigarette smoking and smoky coal emissions.
Gallagher J; Mumford J; Li X; Shank T; Manchester D; Lewtas J
IARC Sci Publ; 1993; (124):283-92. PubMed ID: 8225497
[TBL] [Abstract][Full Text] [Related]
12. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
[TBL] [Abstract][Full Text] [Related]
13. Smoking-related DNA adducts in anal epithelium.
Phillips DH; Hewer A; Scholefield JH; Skinner P
Mutat Res; 2004 Jun; 560(2):167-72. PubMed ID: 15157654
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of pre-existing DNA adducts in rodents exposed to cigarette smoke.
Gupta RC; Arif JM; Gairola CG
Mutat Res; 1999 Mar; 424(1-2):195-205. PubMed ID: 10064861
[TBL] [Abstract][Full Text] [Related]
15. Monitoring carcinogen actions on DNA by 32P-postlabeling.
Randerath K; Randerath E
Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
[TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims.
Schlöbe D; Hölzle D; Hatz D; von Meyer L; Tricker AR; Richter E
Toxicology; 2008 Mar; 245(1-2):154-61. PubMed ID: 18243467
[TBL] [Abstract][Full Text] [Related]
17. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue.
Nath RG; Ocando JE; Guttenplan JB; Chung FL
Cancer Res; 1998 Feb; 58(4):581-4. PubMed ID: 9485001
[TBL] [Abstract][Full Text] [Related]
18. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
19. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.
Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ
Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
